For in-vitro research use only. Not for human consumption.
cagrilintide
Cagrilintide is an acylated, long-acting analog of human amylin. It binds amylin receptors (AMY1, AMY2, AMY3) and calcitonin receptors, modulating appetite, gastric emptying, and postprandial glucose signaling. Its fatty acid acylation extends research half-life through albumin binding.
cagrilintide definition
Cagrilintide is an acylated, long-acting analog of human amylin. It binds amylin receptors (AMY1, AMY2, AMY3) and calcitonin receptors, modulating appetite, gastric emptying, and postprandial glucose signaling. Its fatty acid acylation extends research half-life through albumin binding.
No sequence is listed in the current catalog record for this product.
- CAS
- 1415456-99-3
- MW
- 3754.3 Da
- Sequence
- Not listed
- Half-life
- Discussed in research notes
- Formula
- C166H255N43O50S2
- Purity
- 99.70%
- Form
- Lyophilized powder
- Class
- Amylin Receptor Agonist
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- CAS Number
- 1415456-99-3
- Molecular Weight
- 3754.3 Da
- Molecular Formula
- C₁₆₆H₂₅₅N₄₃O₅₀S₂
- Class
- Amylin Receptor Agonist
- Purity
- ≥99% purity
- Physical Form
- Lyophilized powder
- Storage
- Store at -20°C (long term). Refrigerate after reconstitution.
Research context.
Cagrilintide has been studied as part of the CagriSema combination approach (with semaglutide) in metabolic research. Phase 2 and 3 clinical data have explored amylin-based signaling as a complementary pathway to incretin-based approaches.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
cagrilintide is part of the Nexus GLP-1 & Metabolic catalog. GLP-1, amylin, and multi-agonist metabolic research peptides. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
Long-acting amylin analog, acylated synthetic peptide
Storage: Store at -20°C (long term). Refrigerate after reconstitution.
Technical specifications.
- Product Name: Cagrilintide
- Classification: Amylin Receptor Agonist
- Structural Description: Long-acting amylin analog, acylated synthetic peptide
- CAS Number: 1415456-99-3
- Molecular Weight: 3754.3 Da
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
cagrilintide research FAQ.
What is cagrilintide used for in research?
cagrilintide is supplied for controlled in-vitro research workflows in the GLP-1 & Metabolic category. It is not labeled for human or veterinary use.
Is cagrilintide HPLC verified?
cagrilintide is listed with Nexus lab verification. Current catalog records show 99.70% purity context where batch COA data is available.
Which cagrilintide sizes are available?
Current Nexus variants include 5mg, 10mg, 20mg.
Does cagrilintide include a COA?
Yes. The current Nexus record links cagrilintide to batch NEX-CAGRILINTIDE-2026-0019.
